Vivos Therapeutics enters $8M private placement deal

Medical technology company Vivos Therapeutics entered an agreement with an investor to raise approximately $8 million in a private placement.

Advertisement

The company will offer units consisting of one share of common stock and one warrant exercisable for one share common stock at a price of $1.20 per share for a period of five years and six months from closing, according to a Jan. 5 news release from Vivos. The offering is expected to close Jan. 9.

Vivos Therapeutics said it expects approximately $7.5 million in net proceeds from the offering.

Advertisement

Next Up in Dental Technology

  • Saliva testing is often praised as one of the most innovative tools in dentistry by dental executives and practitioners.  The…

  • Dental technology company Sonendo received $5 million in gross proceeds from a private placement of common stock.  The company will…

Advertisement

Comments are closed.